Middle East & Africa Whole Slide Imaging Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and End User

The whole slide imaging market in Middle East & Africa is expected to grow from US$ 32.95 million in 2022 to US$ 84.33 million by 2028. It is estimated to grow at a CAGR of 17.0% from 2022 to 2028.

Elevating Developments in Telemedicine Technologies

Extensively increasing integration of medical services and digital platforms is leading to increasing popularity and acceptance of digital consultation. Artificial intelligence (AI) is one such technology, which has been reshaping the course of medical imaging and pathology in recent years. Artificial intelligence makes it much easier to utilize digitized consultation images for diagnostics as well as workflow applications. The prominent use of these digitized images is to generate diagnostic algorithms that can augment the diagnostic workflow. In addition, players are also focusing on development of AI-based products. For instance, December 2021, for breast cancer, Roche introduces three artificial intelligence (AI)-based, deep learning image analysis Research Use Only (RUO) algorithms. Artificial intelligence (AI) advances and the growing digitization of pathology are promising approaches to meet the demand for accurate detection, classification, and prediction of patients. Apart from three image analysis, the whole slide analysis workflow with automated pre-computing of the slide image before pathologist assessment and a precise visual overlay highlighting tumor cells with and without nuclear staining.

Market Overview

The whole slide imaging market in the Middle East & Africa is further segmented into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. Growth in healthcare expenditure, high prevalence of cancer in UAE, and availability of quality healthcare is expected to drive the Radiology information systems (RIS) market at a steady growth. Growing healthcare expenditure increases the demand for good healthcare infrastructure, medical facilities. According to Business Monitor International (BMI), in 2018, health expenditures was approximately US$17.9 billion (AED 65.7 billion), and it is estimated to increase up to US$ 22.7 billion (AED 83.1 billion) by 2022. Neuberg Diagnostics, one of the Top 4 Diagnostics Service Provider in India and OptraSCAN Inc., the US-based global digital pathology solutions provider today announced launching of Global TELEPath Network for the pathologist community in UAE, India and South Africa under a new joint venture namely, Neuberg DIGIPATH, Powered by OptraSCANInc. The joint venture is in initial phase and will be formed in three months. The announcement was made at the annual event for the international medical laboratory community, MedLab 2019 in Dubai, United Arab Emirates.

Middle East & Africa Whole Slide Imaging Market Segmentation

The Middle East & Africa whole slide imaging market is segmented into type, application, end user, and country. - Based on type, the market is segmented into hardware, software, and services. The hardware segment registered the largest market share in 2022. Based on application, the market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held a larger market share in 2022. Based on end user, the market is segmented into academic research institutes, hospitals, pharmaceutical and biopharmaceutical companies, and laboratories. The academic research institutes segment held the largest market share in 2022. Based on country, the market is segmented into UAE, Saudi Arabia, South Africa, and Rest of MEA. Japan dominated the market share in 2022. 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; Indica Labs; Leica Biosystems Nussloch GmbH (Danaher); Nikon Corporation; Olympus Corporation; Visiopharm A/S; Akoya Biosciences, Inc.; and Koninklijke Philips N.V. are the leading companies operating in the whole slide imaging market in the region.